PI
CRSP icon

PEAK6 Investments’s CRISPR Therapeutics CRSP Stock Holding History

PEAK6 Investments’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$4.27M Sell
90,900
-94,900
-51% -$4.82M 0.01% 1028
2024
Q2 		$10M Sell
185,800
-102,300
-36% -$5.92M 0.03% 494
2024
Q1 		$19.6M Buy
288,100
+265,600
+1,180% +$19M 0.05% 298
2023
Q4 		$1.41M Buy
22,500
+8,700
+63% +$481K 0.01% 1810
2023
Q3 		$626K Sell
13,800
-30,700
-69% -$1.59M ﹤0.01% 2208
2023
Q2 		$2.5M Buy
44,500
+9,100
+26% +$516K 0.01% 1062
2023
Q1 		$1.6M Sell
35,400
-39,600
-53% -$1.92M 0.01% 1483
2022
Q4 		$3.05M Sell
75,000
-59,100
-44% -$3.14M 0.02% 1017
2022
Q3 		$8.76M Sell
134,100
-200
-0.1% -$14.5K 0.04% 508
2022
Q2 		$7.96M Buy
134,300
+22,900
+21% +$1.35M 0.02% 1012
2022
Q1 		$6.99M Buy
111,400
+26,300
+31% +$1.65M 0.01% 877
2021
Q4 		$6.45M Sell
85,100
-114,600
-57% -$10M 0.01% 976
2021
Q3 		$22.4M Buy
199,700
+46,400
+30% +$5.83M 0.05% 343
2021
Q2 		$24.8M Buy
153,300
+137,300
+858% +$16.7M 0.06% 299
2021
Q1 		$1.95M Sell
16,000
-9,900
-38% -$1.49M ﹤0.01% 1909
2020
Q4 		$3.97M Buy
+25,900
New +$3.06M 0.01% 1259
2019
Q3 		– Sell
-15,800
Closed -$744K – 3820
2019
Q2 		$744K Buy
+15,800
New +$631K ﹤0.01% 2002

Other funds holding CRSP

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

PEAK6 Investments's CRSP Position: Q3 2024 in Review

PEAK6 Investments opened a new position in CRISPR Therapeutics (CRSP) in Q3 2024: 297 shares worth $14K. The stake represents ﹤0.01% of the portfolio and ranks #3221 among its holdings. This is a return to the name: PEAK6 Investments previously reported a position in CRSP as recently as Q4 2023.

PEAK6 Investments first reported a position in CRSP in Q1 2021 and has held it in 11 quarters since. The position peaked at $11.1M in Q4 2022. 416 funds tracked by Wall St. Rank hold CRSP as of Q3 2024.

  • PEAK6 Investments held 297 shares of CRISPR Therapeutics worth $14K as of Q3 2024.
  • CRISPR Therapeutics was a new PEAK6 Investments position in Q3 2024.
  • CRISPR Therapeutics made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #3221 holding.
  • PEAK6 Investments first reported a position in CRISPR Therapeutics in Q1 2021 and has held it in 11 quarters since.
  • PEAK6 Investments's CRISPR Therapeutics position peaked at $11.1M in Q4 2022.
  • 416 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.